PRVB - Provention Bio Inc. (PRVB) CEO Ashleigh Palmer on Q3 2021 Results - Earnings Call Transcript

Provention Bio, Inc. (PRVB) Q3 2021 Earnings Conference Call November 4, 2021 8:30 a.m. ET Company Participants Ashleigh Palmer - Co-Founder, President, CEO, & Director Andrew Drechsler - CFO Francisco Leon - Co-Founder & Chief Scientific Officer Jason Hoitt - Chief Commercial Officer Robert Doody - VP, IR Conference Call Participants Alethia Young - Cantor Fitzgerald Gregory Renza - RBC Capital Markets Thomas Smith - SVB Leerink Raghuram Selvaraju - H.C. Wainwright & Co. David Hoang - SMBC Presentation Operator Good morning. My name is Sarah, and I will be your conference operator today. At this time, I would like to welcome everyone to the Provention Bio call. There will be a question-and-answer session to follow. [Operator Instructions]. Please be advised that this call is being recorded at the company's request. I would now like to turn the call over to Mr. Robert Doody, Vice President of Investor Relations for

For further details see:

Provention Bio, Inc. (PRVB) CEO Ashleigh Palmer on Q3 2021 Results - Earnings Call Transcript